A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005
Clinical trial NCT01047007 · TERMINATED
Trial details
- NCT number
- NCT01047007
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-18
- Primary completion
- 2011-06-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.